长风药业1月14日斥资38.41万港元回购1.2万股
Core Viewpoint - Changfeng Pharmaceutical (02652) announced a share buyback plan, indicating confidence in its stock value and future prospects [1] Group 1: Share Buyback Details - The company will repurchase 12,000 shares at a total cost of HKD 384,100 [1] - The buyback price per share ranges from HKD 31.98 to HKD 32.22 [1]